This article is more than 5 years old. Information may no longer be current.
Recent developments in cosmetic dermatology
The FDA approval of Juvéderm Vollure XC for treating nasolabial folds with results up to 18 months was among the recent developments reported on Healio.com/Dermatology.
Recently reported research included findings that low-level light therapy improved periocular wrinkles and that combination therapy was effective treatment for melasma:
FDA approves Juvéderm Vollure XC for treating nasolabial folds with results up to 18 months
The FDA has approved marketing Juvéderm Vollure XC for correcting moderate-to-severe wrinkles and folds, such as nasolabial folds, in adults aged 21 years and older, according to a news release from Allergan.
In a clinical U.S. trial, a majority (59%) of people treated with Juvéderm Vollure XC, which is formulated with Allergan’s proprietary Vycross technology that blends different molecular weights of hyaluronic acid, had improvement of moderate-to-severe nasolabial folds up to 18 months, according to the release. With Perspectives. Read more
Juvéderm Volbella XC effective for lip, perioral enhancements up to 1 year
Juvéderm Volbella XC treatment for lip and perioral enhancement was safe and effective, with the effects of treatment lasting through 1 year, according to study results published in Dermatologic Surgery.
Roy G. Geronemus, MD, of the Laser & Skin Surgery Center of New York, and colleagues conducted a randomized study of 225 adults (median age, 54 years; 96.9% women) with minimal, mild or moderate lip fullness, using a validated 5-point Allergan Lip Fullness Scale (LFS). Read more
Low-level light therapy improved periocular wrinkles
Low-level light therapy significantly and safely improved facial skin wrinkles, according to study results published in Dermatologic Surgery.
Researchers in Korea conducted a prospective double-blind study of 52 women aged between 30 and 65 years with more than grade 3 lateral periocular wrinkles. Read more
Combination therapy effective treatment for melasma
A combination of Jessner solution and trichloroacetic acid was more effective than trichloroacetic acid alone in treating dark-skinned patients with melasma, according to study results.
Researchers in Egypt studied 24 women (mean age, 34.5 years; skin prototypes IV-V) with bilateral melasma in a split face, right-left, assessor-blinded study. Read more
FACE-Q may be useful for clinical, research purposes
The FACE-Q Eye Module provided clinical utility in assessing adverse outcomes in a cohort of patients undergoing facial aesthetic procedures.
The researchers aimed to more clearly describe the utility of FACE-Q in terms of psychometric evaluation and adverse effects. Read more